The largest database of trusted experimental protocols

11 protocols using sml0843

1

Pharmacokinetic Study of ISRIB in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trans-N,N′-(Cyclohexane-1,4-diyl)bis(2-(4-chlorophenoxy) acetamide (ISRIB, Sigma, SML0843) was dissolved in dimethyl sulfoxide (DMSO) with gentle warming and diluted in polyethylene glycol 400 (PEG400) or saline before injection; 1:1 DMSO and PEG400 or 1% v/v solution of DMSO in saline was used as vehicle control. The choice of dose and timing of ISRIB administration was based on previous reports [14 (link), 17 (link), 18 (link), 24 (link), 32 –34 (link)] and our study of the pharmacokinetics of ISRIB in live rats (see below). 4-(3-phosphonopropyl)piperazine-2-carboxylic acid ((±)-CPP, Alomone, C-175) and 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride (MTEP hydrochloride, Abcam, ab120035) were prepared in distilled water and diluted with saline to the required concentration.
+ Open protocol
+ Expand
2

Regulation of Stress Granule Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ISRIB (200 nM; Sigma SML0843) and cycloheximide (100 µg/ml; Sigma C4859) treatment was performed for 30 min before adding sodium arsenite (0.5 mM; Sigma 35000–1 L-R) or blue light. For sodium arsenite treatment, medium was changed to medium containing 0.25 mM or 0.5 mM sodium arsenite for 30 or 45 min as indicated in figure legends. For heat shock treatment, cells were transferred to a 42°C humidified incubator with 5% CO2 for 1 hr.
+ Open protocol
+ Expand
3

Tunicamycin-induced ER stress response

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells (80% confluent, 7X106 cells) in F12 media (30 mL, ThermoFisher), 10% FBS, and 1X antibiotic/antimycotic were treated with tunicamycin (Tm, 2.5 μg/mL in DMSO, 30 μL). To some samples were added Gb (50 μM in ethanol, 30 μL, Sigma-Aldrich, catalog number G110), Sephin1 (10 mg/mL in 0.1% DMSO, Sigma, catalog number SML 1356), and/or ISRIB (1 mg/mL in 0.1% DMSO, Sigma, catalog number SML 0843). After 6 hours incubation at 37°C, cells were harvested and lysed as described earlier. Each lysate (100 μg total protein) was treated with 1X Laemmli sample buffer and heated at 95°C for 1 min. The proteins in the lysates were separated by 10% SDS-PAGE gels, followed by visualization with Sypro®Ruby total protein stain or immunoblotting after transfer to PVDF membrane (Milipore Immobilon-P) using antibodies to COPS5 (Santa Cruz-SC-9074) or G3BP1 (Santa Cruz-365338). The gels images were obtained using a Typhoon imager (GE Healthcare Life Sciences).
+ Open protocol
+ Expand
4

Intraperitoneally Administered ISRIB

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single dose of ISRIB (SML0843, Sigma, St. Louis, MO, USA) at 2.5 mg kg−1 (diluted in 6.25% DMSO and 6.25% PEG300) or vehicle was administered intraperitoneally 90 min prior to behavioral testing, protein analyses, or electrophysiological recordings.37 (link)
+ Open protocol
+ Expand
5

Optic Nerve Crush and Neuroprotective Interventions

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice, ZnT-3 conditional knockout mice (Gempharmatech Co., Ltd., Nanjing, China), and littermate controls were used in this study. Mice were housed in standard cages in a specific pathogen-free facility on a 12 h light/dark cycle with ad libitum access to food and water. Mice were randomly allocated for each experiment. Regarding the sex factor, which is generally irrelevant to eye morphology [38 (link)], both male and female mice were randomly used. Optic nerve surgeries were performed on 6 to 8 weeks old mice (average body weight, 20–26 g) under general anesthesia, as previously described [39 (link)]. Immediately after optic nerve crush (ONC), single- or combined-use of TPEN (100 μM; 616394, Millipore, Burlington, MA, USA), C16 (4, 20, 100 μM; I9785, Sigma-Aldrich, St. Louis, MO, USA), ISRIB (10, 100, 1000 μM; SML0843, Sigma-Aldrich), or vehicle was administered by intraocular injection (3 μL per eye).
+ Open protocol
+ Expand
6

Quantifying Cell Viability Under Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2AF1 WT, S34F and Q157R HEL cells were plated at
5×104 cells/ml in 96-well plates and induced with 1
μg/ml doxycycline for 24 hours. Then, cells were spun down at
500×g for 5 min and resuspended in RPMI 1640 containing 1
μg/ml doxycycline, 500 μM sodium arsenite (Sigma-Aldrich, Cat
#S7400) and 20 nM ISRIB (Sigma-Aldrich, Cat #SML0843) or vehicle (DMSO).
After 24 hours, cell viability measurements were obtained by flow cytometry
and by colorimetric WST-1 assay (Abcam, Cat #ab65475). For flow cytometry
analysis, cells were stained with 1.5 μl 7-aminoactinomycin D (7-AAD)
solution (STEMCELL Technologies, Cat #75001) and data were acquired by LSR
Fortessa (BD Biosciences, Yale Flow Cytometry Facility). The percentage of
viable (7-AAD) cells was calculated by FlowJo software
(BD Biosciences) after debris removal. For the WST-1 assay, cells were
incubated with 10 μl WST-1 reagent at 37°C for 2 hours. The
level of cell viability was assessed measuring the absorbance at 450 nm with
a plate reader.
+ Open protocol
+ Expand
7

Cellular Perturbation Assays with Pharmacological Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated for the indicated times with 20 μM CCCP (carbonyl cyanide m-chlorophenyl hydrazone; Sigma-Aldrich, C2759), 10 μM OM (oligomycin A; MedChem Express, HY-16589; Sigma-Aldrich, 75351), 20 μg/mL cycloheximide (Sigma-Aldrich, C4859), 10 μM tunicamycin (MedChem Express, HY-A0098), 200 nM ISRIB (Sigma-Aldrich, SML0843).
Cells were plated 24 h before transfection with polyethylenimine (PEI 25000, Polysciences) or turbofectin (OriGene Technologies). Cells were treated, harvested, passaged or placed on selection medium 24 h after transfection.
Transfections of siRNAs (siNTC, D-001810-10-05, Horizon Discovery; siTOMM40, M-012732-00-0010, Horizon Discovery; siTIMM23, 1299001, Thermo Fisher Scientific) were performed using Lipofectamine RNAiMAX Transfection Reagent (Thermo Fisher Scientific) following the manufacturer’s instructions.
For induction of shRNAs from the pLKO vector, cells were treated with 500 ng/mL doxycycline hyclate (Biomol, Cay14422-1) for 5 days.
For growth assays, cells were counted and seeded at equal numbers in triplicate wells on day 0 in DMSO (control) or 200 nM ISRIB-containing medium. Cells were passaged every 2–3 days and counted using Countess® Cell Counting Chamber Slides (Thermo Fisher Scientific, C10228). Counts shown in bar graphs represent the ratio of ISRIB-treated cells versus DMSO-treated controls.
+ Open protocol
+ Expand
8

Protein Inhibition for Cellular Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carbobenzoxy-l-leucyl-l-leucyl-l-leucinal (MG132; Sigma-Aldrich 474790, Darmstadt, Germany) and integrated stress response inhibitor (ISRIB; Sigma-Aldrich SML0843) were dissolved in DMSO and cells were treated with final concentrations as described.
+ Open protocol
+ Expand
9

Screening Neuroprotective Drugs against Hypoxia and Hypoglycemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce HX condition, nf-hSCOs were cultured in a maturation medium containing 300 µM cobalt chloride (CoCl2; Sigma). Hypoglycemic condition (HG) was induced by replacing the medium with glucose-free neurobasal medium (Thermo Fisher Scientific, Waltham, MA) mixed with 2.5 mM Glucose solution (Thermo Fisher Scientific). A combination of CoCl2 with hypoglycemic condition (HXHG) was induced in hypoglycemic medium containing 300 µM CoCl2. For screening of drugs, nf-hSCOs were treated with drugs 2 days prior to exposure to HXHG conditions, and subsequently exposed to HXHG condition–containing drugs (ISRIB, 10 nM; Sigma, SML0843; rapamycin, 5 μM; Sigma, R0395; metformin, 10 mM; Sigma, PHR1084; minocyclin, 2 µM; sigma, M9511). The medium was changed daily.
+ Open protocol
+ Expand
10

Astrocyte Inflammatory Response Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Astrocytes cultures were incubated in serum‐free condition for 24 h and pretreated for 30 min with UB‐SCG‐51 or p‐eIF2α signal inhibitor (Sigma, SML0843), followed by recombinant T/I/C: IL‐1α (3 ng/mL, Peprotech, Thermo Fisher), TNF‐α (30 ng/mL, R&D), C1q (400 ng/mL, R&D), or PBS for 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!